Phenylacetic acid API Manufacturers
compare suppliers & get competitive offers
To view suppliers for this material, you need to be logged in first.
This is because of international laws regarding narcotic materials. Furthermore, the contents of this page are only accessible if you are professionaly active in the pharmaceutical industry. In case you are, it is possible to register on our platform, and after your account is approved by our team you will be able to view suppliers and send your request.
Looking for Phenylacetic acid API 103-82-2?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Phenylacetic acid. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Phenylacetic acid
- Synonyms:
- benzeneacetic acid
- Cas Number:
- 103-82-2
- DrugBank number:
- DB09269
- Unique Ingredient Identifier:
- ER5I1W795A
About Phenylacetic acid
What can you use it for? Phenylacetic acid is an organic compound containing a phenyl functional group and a carboxylic acid functional group. It is a white solid with a disagreeable odor. Because it is used in the illicit production of phenylacetone (used in the manufacture of substituted amphetamines), it is subject to controls in countries including the United States and China.
Do you want to buy this product? Send an inquiry to the listed suppliers that meets your quality requirements
Phenylacetic acid is a type of Other antibacterials
The category of pther antibacterials in the pharmaceutical API (Active Pharmaceutical Ingredient) industry encompasses a diverse range of antibacterial substances that are not classified under specific subcategories. These APIs exhibit potent antibacterial activity against various bacteria and play a crucial role in combating bacterial infections.
The Other antibacterials category includes several subclasses of pharmaceutical APIs, such as nitroimidazoles, fusidanes, polymyxins, and glycopeptides. Each subclass comprises specific chemical compounds that target different types of bacteria through distinct mechanisms of action.
Nitroimidazoles are effective against anaerobic bacteria and protozoa by interfering with their DNA replication. They are commonly used in the treatment of infections in the gastrointestinal tract, pelvic area, and respiratory system. Fusidanes, on the other hand, inhibit bacterial protein synthesis and are particularly active against Gram-positive bacteria. They find application in treating skin and soft tissue infections caused by Staphylococcus aureus.
Polymyxins are cyclic peptides that disrupt the integrity of bacterial cell membranes, rendering them inactive. These APIs are potent against Gram-negative bacteria and are often reserved for multidrug-resistant strains.
Glycopeptides, such as vancomycin, are essential for combating Gram-positive bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA). They inhibit bacterial cell wall synthesis, leading to bacterial death.
The Other antibacterials category plays a critical role in providing effective treatment options for bacterial infections, particularly when other classes of antibacterials have shown limited efficacy. Pharmaceutical companies continually explore and develop new compounds within this category to address emerging antibiotic resistance and enhance patient care.
